SCHEMBL15328121

SCHEMBL15328121

Cc1cc(N2CCOCC2)cc(C2CC2)c1C(=O)NCc1ccc(C(F)(F)F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 1/20 0.45
GAA P10253 1/20 0.43
LMNA P02545 3/20 0.43
MAPT P10636 1/20 0.43
SRPK1 Q96SB4 1/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC6 Q9UBN7 1/20 0.42
EGFR P00533 1/20 0.42
CDK2 P24941 1/20 0.42
EPHX2 P34913 1/20 0.41
NAPEPLD Q6IQ20 1/20 0.41
TP53 P04637 1/20 0.41
THRB P10828 1/20 0.41
AKR1C3 P42330 1/20 0.40
CD274 Q9NZQ7 1/20 0.40
KLKB1 P03952 1/20 0.40
KLK1 P06870 1/20 0.40
KDM1A O60341 1/20 0.40
NAMPT P43490 1/20 0.40
CA1 P00915 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15328484 0.90 GAA (0.48) GAALMNAHDAC1HDAC6TP53
SCHEMBL15328669 0.88 CYP2C9 (0.45) EPHX2
SCHEMBL15328400 0.88 KMT2A (0.47) LMNAEGFRCDK2TP53THRB
SCHEMBL15328435 0.87 NAMPT (0.40) BRAFMAPTNAMPTHIF1AEPAS1
SCHEMBL15328442 0.85 KMT2A (0.47) LMNAEGFRCDK2TP53THRB
SCHEMBL15328525 0.84 BRAF (0.45) BRAFGAALMNAMAPTSRPK1
SCHEMBL15328673 0.83 BRAF (0.45) BRAFGAALMNAMAPTSRPK1
SCHEMBL2130339 0.82 NAPEPLD (0.49) BRAFGAALMNASRPK1NAPEPLD
SCHEMBL30795136 0.82 NAPEPLD (0.49) BRAFGAALMNASRPK1NAPEPLD
SCHEMBL15328436 0.81 KMT2A (0.44) LMNAEGFRCDK2TP53THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108936-B2 Substituted 4-aminobenzamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2015-08-18 US claimed
EP-2844645-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2015-03-11 EP claimed
WO-2013156155-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2013-10-24 WO claimed
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2013-10-24 US claimed
US-9108936-B2 Substituted 4-aminobenzamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2015-08-18 US disclosed
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2013-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281452-A1 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS KCNJ2, KCNQ2, KCNQ1 BRAF 2639/4885GAA 3329/4885LMNA 1359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.